Wound healing migration assays, Transwell migration assays and mouse model assays have additionally suggested that AA may function as a potent tumor angiogenesis inhibitor by targeting the Src/FAK/Rho GTPase signaling pathway, leading to significant suppression of prostate tumor growth at low dosage levels (5–50 μM) [11]. The gene discussed is SRC; the disease is prostate neoplasm.